VHT ETF Analysis: Health Care Shares | NYSE
Health | NYSE, USA | Market Cap: 18.150m USD | 12M Return: 25.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 79.5M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Vanguard Health Care Index Fund ETF (VHT) employs a passive indexing strategy designed to track the performance of a benchmark index composed of large-, mid-, and small-capitalization U.S. companies classified within the health care sector under the Global Industry Classification Standard (GICS). The fund aims for full replication, holding each constituent stock in approximately the same proportion as its weighting in the underlying index. The fund is classified as non-diversified.
The GICS health care sector broadly encompasses industries such as pharmaceuticals, biotechnology, medical equipment, health care providers and services, and health care technology. As an exchange-traded fund listed on the NYSE, VHT offers investors exposure to the U.S. health care market through a single, passively managed vehicle that trades like a stock.
- Medicare drug price negotiations pressure pharma profit margins
- GLP-1 obesity drug demand lifts pharma and device makers
- Interest rate cuts boost biotech valuations and M&A activity
As of July 28, 2026, the stock is trading at USD 306.67 with a total of 167,214 shares traded. Over the past week, the price has changed by +2.40%, over one month by +1.40%, over three months by +14.49% and over the past year by +25.09%.
Current recommended Stop Loss: 301.00 (which is 1.8% or 1.2 ATR below the current price).
Health Care Shares has no consensus analysts rating.